Follicular Fluid Zinc Level and Oocyte Maturity and Embryo Quality in Women with Polycystic Ovary Syndrome

Document Type : Original Article


1 Department of Obstetrics and Gynecology, School of Medicine, Research and Clinical Center for Infertility, Dezful University of Medical Sciences, Dezful, Iran

2 Department of Histology, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran

3 Department of Pharmacology, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran

4 School of Medicine, Dezful University of Medical Sciences, Dezful, Iran

5 Department of Histology, School of Medicine, Research and Clinical Center for Infertility, Dezful University of Medical Sciences, Dezful, Iran


Polycystic ovary syndrome (PCOS) is considered to be one of the most common endocrine disorders in women of reproductive age. Zinc, a vital trace element in the body, plays a key role in maintaining health, especially due to its antioxidant role. On the other hand, lack of antioxidants and oxidative stress can adversely affect oocytes quality and consequently fertility rate. The available studiesthat report the effect of follicular fluid (FF) zinc in terms of the number and quality of the oocytes in infertile women with PCOS, are few and not consistent. We decided to
investigate this issue.
Materials and Methods:
In this cross-sectional study, from the women with PCOS referring to Omolbanin Hospital, Dezful, Iran (February to December 2019), a total of 90 samples (follicular fluid, oocytes, and embryos) were collected from those who had undergone in vitro fertilization (IVF). To measure zinc level in follicular fluid, high performance liquid chromatograpy (HPLC) was utilized. Also, oocytes maturity and embryos quality evaluation was performed using inverted optical microscopy. One-way ANOVA and Fisher’s least significant difference (LSD) were used for data analysis.
The amount of FF zinc was not associated with any significant differences in the number of oocytes and metaphase I (MI) and germinal vesicle (GV) oocytes, but a significant decrease was observed in the number of metaphase II (MII) oocytes at zinc values lessthan 35 μg/dL. The FF zinc levels lessthan 35 μg/dL were also significantlyassociated with decreased embryo quality.
A significant relationship was found between the level of FF zinc and the quality and the number of oocytes taken from the ovaries of infertile patients with PCOS history who were candidates for IVF treatment as well as the number of high quality embryos.


1. Özer A, Bakacak M, Kıran H, Ercan Ö, Kös tü B, Kanat-Pektaş M, et al. Increased oxidative s tress is associated with insulin resis tance and infertility in polycys tic ovary syndrome. Ginekologia Polska. 2016; 87(11): 733-738.
2. Hwang KR, Choi YM, Kim JJ, Chae SJ, Park KE, Jeon HW, et al. Effects of insulin-sensitizing agents and insulin resis tance in women with polycys tic ovary syndrome. Clin Exp Reprod Med. 2013; 40(2): 100-105.
3. Álvarez-Blasco F, Botella-Carretero JI, San Millán JL, Escobar-Morreale HF. Prevalence and characteris tics of the polycys tic ovary syndrome in overweight and obese women. Arch Intern Med. 2006; 166(19): 2081-2086.
4. Zhang Y, Liu L, Yin TL, Yang J, Xiong CL. Follicular metabolic changes and effects on oocyte quality in polycys tic ovary syndrome patients. Oncotarget. 2017; 8(46): 80472-80480.
5. Dumesic DA, Lobo RA. Cancer risk and PCOS. S teroids. 2013; 78(8): 782-785.
6. Afiat M, Khadem N, Nayeri E, Jalali R, Akhlaghi S, Akhgari E, et al. Comparison of oocyte and embryo quality in women with polycys tic ovary syndrome and the control group candidate for in vitro fertilization and intracytoplasmic sperm injection. Int J Women's Health Reprod Sci. 2021; 9(3): 1-7.
7. Arya BK, Haq AU, Chaudhury K. Oocyte quality reflected by follicular fluid analysis in poly cys tic ovary syndrome (PCOS): a hypothesis based on intermediates of energy metabolism. Med Hypotheses. 2012; 78(4): 475-478.
8. Singh AK, Chattopadhyay R, Chakravarty B, Chaudhury K. Markers of oxidative s tress in follicular fluid of women with endometriosis and tubal infertility undergoing IVF. Reprod Toxicol. 2013; 42: 116-124.
9. Kim YS, Kim MS, Lee SH, Choi BC, Lim JM, Cha KY, et al. Proteomic analysis of recurrent spontaneous abortion: identification of an inadequately expressed set of proteins in human follicular fluid. Proteomics. 2006; 6(11): 3445-3454.
10. Tolunay HE, Şükür YE, Ozkavukcu S, Seval MM, Ateş C, Türksoy VA, et al. Heavy metal and trace element concentrations in blood and follicular fluid affect ART outcome. Eur J Obs tet Gynecol Reprod Biol. 2016; 198: 73-77.
11. Prasad AS. Zinc: mechanisms of hos t defense. J Nutr. 2007; 137(5): 1345-1349.
12. Bedwal RS, Bahuguna A. Zinc, copper and selenium in reproduction. Experientia. 1994; 50(7): 626-640.
13. Ménézo Y, Pluntz L, Chouteau J, Gurgan T, Demirol A, Dalleac A, et al. Zinc concentrations in serum and follicular fluid during ovarian s timulation and expression of Zn2+ transporters in human oocytes and cumulus cells. Reprod Biomed Online. 2011; 22(6): 647-652.
14. Özkaya MO, Nazıroğlu M, Barak C, Berkkanoglu M. Effects of multivitamin/mineral supplementation on trace element levels in serum and follicular fluid of women undergoing in vitro fertilization (IVF). Biol Trace Elem Res. 2011; 139(1): 1-9.
15. Poormoosavi SM, Behmanesh MA, Janati S, Najafzadehvarzi H. Level of bisphenol a in follicular fluid and serum and oocyte morphology in patients undergoing IVF treatment. J Family Reprod Health. 2019; 13(3): 154-159.
16. Bahadori MH, Sharami SH, Fakor F, Milani F, Pourmarzi D, Dalil-Heirati SF. Level of vitamin e in follicular fluid and serum and oocyte morphology and embryo quality in patients undergoing IVF treatment. J Family Reprod Health. 2017; 11(2): 74-81.
17. Scott L, Alvero R, Leondires M, Miller B. The morphology of human pronuclear embryos is positively related to blas tocys t development and implantation. Hum Reprod. 2000; 15(11): 2394-2403.
18. Sparks A. An atlas of human gametes and conceptuses: an illus trated reference for assis ted reproductive technology. In: Veeck LL, editor.1s t ed. CRC Press; 1999.
19. Boland M, Lonergan P, O'callaghan D. Effect of nutrition on endocrine parameters, ovarian physiology, and oocyte and embryo development. Theriogenology. 2001; 55(6): 1323-1340.
20. Kurdoglu Z, Kurdoglu M, Demir H, Sahin HG. Serum trace elements and heavy metals in polycys tic ovary syndrome. Hum Exp Toxicol. 2012; 31(5): 452-456.
21. Sun Y, Lin Y, Niu M, Kang Y, Du S, Zheng B. Follicular fluid concentrations of zinc and copper are positively associated with in vitro fertilization outcomes. Int J Clin Exp Med. 2017; 10(2): 3547-3553.
22. Seleem AK, El Refaeey AA, Shaalan D, Sherbiny Y, Badawy A. Superoxide dismutase in polycys tic ovary syndrome patients undergoing intracytoplasmic sperm injection. J Assis t Reprod Genet. 2014; 31(4): 499-504.
23. Pang W, Leng X, Lu H, Yang H, Song N, Tan L, et al. Depletion of intracellular zinc induces apoptosis of cultured hippocampal neurons through suppression of ERK signaling pathway and activation of caspase-3. Neurosci Lett. 2013; 552: 140-145.
24. Kumar S, Mishra V, Thaker R, Gor M, Perumal S, Joshi P, et al. Role of environmental factors & oxidative s tress with respect to in vitro fertilization outcome. Indian J Med Res. 2018; 148 Suppl 1: S125-S133.
25. Jeon Y, Yoon JD, Cai L, Hwang SU, Kim E, Zheng Z, et al. Zinc deficiency during in vitro maturation of porcine oocytes causes meiotic block and developmental failure. Mol Med Rep. 2015; 12(4): 5973-5982.
26. Tian X, Diaz FJ. Acute dietary zinc deficiency before conception compromises oocyte epigenetic programming and disrupts embryonic development. Dev Biol. 2013; 376(1): 51-61.
27. Tian XI, Diaz FJ. Zinc deficiency during oocyte maturation causes defects in preimplantation embryonic development. Biol Reprod. 2012; 87(Suppl 1): 199.
28. Özkaya MO, Nazıroğlu M. Multivitamin and mineral supplementation modulates oxidative s tress and antioxidant vitamin levels in serum and follicular fluid of women undergoing in vitro fertilization. Fertil S teril. 2010; 94(6): 2465-2466.